News & Perspective

Sep 11, 2009

Sep 11, 2009

Roche boosts Tamiflu supply, addresses resistance

(CIDRAP News) – Officials from Roche today said the company is producing Tamiflu (oseltamivir) at near-capacity levels and is collaborating on dozens of research studies, focusing on groups such as pregnant women who are at higher risk of complications from pandemic H1N1 flu.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»